Search

Dalia Tohamy,1 Mohamed Sharaf,1 Khaled Abdelazeem,1 Mohamed GA Saleh,1 Mahmoud F Rateb,1 Wael Soliman,1 Salma M Kedwany,1 Mohamed Omar Abdelmalek,2 Mohammed A Medhat,2 Amal M Tohamy,3 Hany Mahmoud4 1Ophthalmology Department, Assiut University, Assiut, Egypt; 2Tropical Medicine and Gastroenterology Department, Assiut University, Assiut, Egypt; 3Neuology Department, Assiut University, Assiut, Egypt; 4Ophthalmology Department, Sohag University, Sohag, EgyptCorrespondence: Hany MahmoudOphthalmology Department, Sohag University, Almohafza Street, Sohag, 82511, EgyptTel +20 1024368111Email drhanymahmoud@gmail.comPurpose: To evaluate the ocular manifestations of post-acute COVID-19 syndrome.Methods: A retrospective, comparative study included 100 patients who had recovered from COVID-19 and 100 controls who were recruited by stratified randomization from hospital registration system and analyzed regarding history, full ophthalmological examination, general examination including internal medicine and neurological evaluation. Laboratory tests were done.Results: Mean±SD of age were 55.5 ± 6.2 in COVID group vs 56.5 ± 5.8 in control group; P value = 0.7. In COVID group, 57 patients (57%) were males vs 51 patients (51%) in control group (P value = 0.39), the other compared parameters including history and risk factors showed non-significant difference except for ESR and D-dimer which were elevated in COVID group. In COVID group, 5 patients (5%) were having retinal vascular occlusion, 2 patients (2%) were having anterior ischemic optic neuropathy AION, 3 patients (3%) were having uveitis and 2 patients (2%) were having central serous chorioretinopathy CSCR. While in control group, 2 patients (2%) were having retinal vascular occlusion, and none had AION, uveitis or CSCR (P value = 0.006).Conclusion: Post-acute COVID-19 syndrome could affect the eyes in the form of coagulation problems, neurological morbidities, and other manifestations. This necessitates meticulous follow-up of recovered patients from COVID-19.Keywords: eye, post-acute COVID-19, Upper Egypt, coagulation, follow-up

Salinity is a major constraint for crop health and productivity, particularly on arid, semiarid, and otherwise marginal soils, such as quarry residue. Quarries are a main pillar of national income in Palestine but have a long-lasting toll on the environment. We examined barley (Hordeum vulgare L.), another pillar of the Palestinian economy and one of the most important crops in the world, in this regard for its tolerance to salinity stress. This study is the first to evaluate the impact of salinity (50, 85, 120, and 175 mM NaCl) on seed germination, early growth stage, and morpho-anatomy on ten pre-selected certified Palestinian barley cultivars (Baladi, Improved Baladi, Rihan, ICARDA 1, ICARDA 15, ACSAD 68, ACSAD 176, ACSAD 1417, ACSAD 1732, and ACSAD 1744) to assess their potential for a successful growth start under adverse saline conditions. In addition, soil samples from quarries in Hebron governorate were randomly selected and tested for salinity level, electrical conductivity, and total of soluble salts for a first rough overview of options for applying our results, since local data are often scarce or outdated. The examined soil samples reached electrical conductivity (EC) ranges of 1.81 × 10−4–9.071 × 10−4 dS m−1, which are below the normal EC (11–57 × 10−4 dS m−1). This result may contraindicate the hypothesis that quarry lands always suffer from salinity stress. Cultivars such as ACSAD 68 and Icarda 15 proved very sensitive to higher salinity stress with high G50 (time point when 50% of seeds have germinated) at 4.4 d, with 120 mM NaCl (ACSAD 68) or incalculable amounts (Icarda 15) and just 50 and 20% total germination, respectively. Concentrations of 175 mM NaCl were found in ACSAD 176 and Improved Baladi (no G50, 37 and 30% germination, respectively). Some cultivars showed a moderate to high resilience to salinity, such as ICARDA I, ACSAD 1417, and ACSAD 1744, which reached > 80% seed germination at 120 mM NaCl and >60% at 175 mM NaCl, and G50 within 1.5–2.2 days; the most resilient was ACSAD 1732 with G50 < 2 days and germination still >80% at 175 mM NaCl. This is strongly supported by the monitored growth parameters. In conclusion, ACSAD1732 and Icarda 1 cultivars are highly recommended for cultivation in areas of low precipitation and high salt accumulation. In addition, the land and/or soil of quarries, their landfills, and nearby areas in Palestine may be fit for barley cultivation with recommended cultivars regarding salinity stress.

This study aims to review the available data regarding the central role of immunity in combating SARS-CoV-2 infection and in the generation of protection by vaccination against COVID-19 in different age groups. Physiologically, the immune response and the components involved in it are variable, both functionally and quantitatively, in neonates, infants, children, adolescents, and adults. These immunological differences are mirrored during COVID-19 infection and in the post-vaccination period. The outcome of SARS-CoV-2 infection is greatly dependent on the reaction orchestrated by the immune system. This is clearly obvious in relation to the clinical status of COVID-19 infection, which can be symptomless, mild, moderate, or severe. Even the complications of the disease show a proportional pattern in relation to the immune response. On the contrary, the commonly used anti-COVID-19 vaccines generate protective humoral and cellular immunity. The magnitude of this immunity and the components involved in it are discussed in detail. Furthermore, many of the adverse effects of these vaccines can be explained on the basis of immune reactions against the different components of the vaccines. Regarding the appropriate choice of vaccine for different age groups, many factors have to be considered. This is a cornerstone, particularly in the following age groups: 1 day to 5 years, 6 to 11 years, and 12 to 17 years. Many factors are involved in deciding the route, doses, and schedule of vaccination for children. Another important issue in this dilemma is the hesitancy of families in making the decision about whether to vaccinate their children. Added to these difficulties is the choice by health authorities and governments concerning whether to make children’s vaccination compulsory. In this respect, although rare and limited, adverse effects of vaccines in children have been detected, some of which, unfortunately, have been serious or even fatal. However, to achieve comprehensive control over COVID-19 in communities, both children and adults have to be vaccinated, as the former group represents a reservoir for viral transmission. The understanding of the various immunological mechanisms involved in SARS-CoV-2 infection and in the preparation and application of its vaccines has given the sciences a great opportunity to further deepen and expand immunological knowledge. This will hopefully be reflected positively on other diseases through gaining an immunological background that may aid in diagnosis and therapy. Humanity is still in continuous conflict with SARS-CoV-2 infection and will be for a while, but the future is expected to be in favor of the prevention and control of this disease.

The efficient transfer of nutrients to plants in the form of biofertilizers on poor substrate was investigated. Biochar and dried algae biomass as well as mineral fertilizer were used to test the growth of the Palestinian ‘Rehan’ barley cultivar under salinity stress (4, 8, and 16 mS/cm EC). Rehan cultivar showed resilience to moderate levels of salinity and could still grow under high salinity stress (16 mS/cm EC). Rehan barley possessed better growth at early growth stage under the applied biofertilizers such as dried freshwater algal biomass (Chlorella vulgaris) and nutrient-laden biochar. It showed better growth than wheat (ssp. scirocco) under the same conditions. Its growth was highly improved by biochar treatment in low and moderate salinity conditions. Moreover, the combined effect between biochar and dried algae biomass could improve Rehan barley growth, but less than the effect of each biofertilizer separately. The biofertilizers affected most plant growth parameters under the salinity level of 4 and 8 mS/cm EC positively, while the growth declined again at 16 mS/cm EC. Overall, the biochar treatment showed the same effect as the mineral fertilizer on most of the parameters. The dried algae biomass and biochar also affected soil conditions. The highest soil water content (15.09%) was found in algae biomass treatments with 16 mS/cm EC. Biochar with 8 and 16 mS/cm EC had the highest pH value (8.63) near the rhizospheres. The nitrogen level was highest in the bottom soil sample (0.28 g N/kg soil) for biochar with 0 and 4 mS/cm EC. Meanwhile, the phosphate concentration was the highest (3.3 mg PO3−2/kg soil) in algae fertilizer treatments with 0 mS/cm EC in the bottom soil sample and lowest (4.14 mg PO3−2/kg soil) for the biochar with 8 mS/cm EC. The dried algae biomass and the biochar treatments can subsequently be viewed as conditioner substrates for improving the quality and fertility of the soil. Where possible, they should be considered as complement or replacement of mineral and manure fertilization to improve the impact on soil and environment.

This article compares the outcomes of early (¿24 hours) versus late (>24 hours) surgical revascularization in patients with acute myocardial infarction (AMI) and normal or diminished left ventricular ejection fraction (LVEF). The study analyzed data from 1227 AMI patients and used propensity score matching to create balanced subgroups. The results showed that early revascularization did not improve mortality or long-term survival in either group, but it did significantly enhance LVEF in patients with reduced baseline levels. The authors suggest that further randomized trials are needed to determine if early surgical intervention can benefit AMI patients beyond the initial hours postinfarction. [Extracted from the article]

The study aimed to identify the types and methods of administrative communication that are used between departments at King Faisal Hospital. The study also sought to identify the most important determinants that stand in the way of effective administrative communication and to explain their relationship to health service provision at King Faisal Hospital. The study adopted the descriptive analytical approach through a questionnaire that was applied to a sample of 282 employees at King Faisal Hospital. The results of the study showed that there are no significant organizational determinants of communication and environmental determinants of communication. The results showed the absence of psychosocial determinants, while the presence of personal communication determinants was found at a moderate level of importance. On the other hand, the study found a high level of health service provision. In addition, the results showed a statistically significant relationship at the level of statistical significance (0.05≥α) for the determinants of administrative communication (organizational, personal, environmental, and psychosocial) on health service provision. The study recommended paying attention to personal determinants in communication by improving communication methods and the nature of relationships between the manager and employees. [ABSTRACT FROM AUTHOR]

Since the beginning of 2020, the world has been in a race to develop vaccines that can control the COVID-19 pandemic. More than 250 projects have been initiated for this purpose, but only 14 of them have been authorized for use, despite being in phase 3 clinical trials. More than 40 other vaccines are also in phase 1/2 clinical trials and show promising outcomes. Regarding the appropriate choice of vaccines for each country or region, we reviewed the currently used vaccines in light of the different influencing parameters. These factors include the mode of action, dosage protocol, age group of the vaccinee, side effects, storage conditions, mounted immune response, and cost. Technically, there are seven types of vaccines developed against SARS-CoV-2: messenger RNA (mRNA), nonreplicating and replicating vectors, inactivated viruses, protein subunits, viral-like particles, DNA vaccines, and live attenuated vaccines. The mRNA type is being used for the first time in humans. Unfortunately, mutated variants of SARS-CoV-2 have started to appear worldwide, and researchers are investigating the effects of the currently used vaccines on them. There are many concerns regarding the long-term protection afforded by these vaccines and their side effects, and whether they require future modifications to be effective against the mutated variants. The development of new vaccines using more advanced technology is paramount for overcoming the difficulties in controlling the COVID-19 pandemic across the world.

Byline: M. Elbaset, Osama. Ezzat, Mostafa. Elgamal, M. Sharaf, A. Elmeniar, Abdalla. Abdelhamid, Yasser. Osman Introduction: Some patients with ureteropelvic junction obstruction (UPJO) have supranormal differential renal function (snDRF). We [...]